Cementless Total Knee System (TKS) Market

Cementless Total Knee System (TKS) Market Analysis

The Cementless Total Knee System Market is expected to register a CAGR of 6.5% during the forecast period.

The rising number of target diseases and sports injuries, as well as the growing benefits of cementless total knee replacement systems, are major factors driving the growth of the market studied. For instance, according to the data updated by the American Academy of Orthopaedic Surgeons in February 2024, more than 700,000 total knee replacements are performed annually in the United States, which, in turn, is anticipated to elevate the need for a cementless total knee system. Such factors are expected to boost the adoption of cementless total knee systems, contributing to market growth.

Moreover, according to an article published by Lancet Rheumatology in August 2023, nearly 1 billion people are projected to be living with osteoarthritis, the most common form of arthritis, by 2050. The source also stated that 15% of individuals aged 30 and older experience osteoarthritis around the world. Therefore, the increase in the number of arthritis patients will increase the need for various surgeries, such as cementless total knee replacement surgery, which is poised to accelerate the cementless total knee system (TKS) market.

In addition, new product launches and strategic activities by major players in the market are positively affecting the growth of the market studied. For instance, in January 2022, Smith & Nephew acquired Engage Surgical. Engage Surgical manufactures a cementless knee implant. The partial knee implant is optimized for robotics and will work along with Smith & Nephew’s CORI surgical system in the future. Thus, such developments are expected to boost the usage of cementless total knee systems during the forecast period.

Therefore, owing to factors such as the increasing prevalence of orthopedic disorders and the rising product launches, it is anticipated that the studied market will witness growth over the analysis period. However, the high cost of the cementless total knee system and procedure may impede the market's growth.

Cementless Total Knee System (TKS) Market Trends

The Tibial Component Segment is Expected to Witness Significant Growth During the Forecast Period

In tibial component surgeries, the top of the tibia, or shinbone, is replaced. The process is the same as the femoral component, as all the damaged tissues are cut away, and the tibia is shaped to fit the joint replacement. Then, the prosthetic component, called the tibial tray, is put in place. The increasing number of tibial component replacements, the growing prevalence of arthritis, and the rising geriatric population are expected to enhance segment growth.

Moreover, the rising prevalence of osteoarthritis and sports injuries is also expected to enhance segment growth. For instance, as per the Sports Accident Statistics report updated by LegalMatch in August 2022, injuries to the anterior cruciate ligament (ACL) occur roughly 150,000 times every year in the United States. In addition, female basketball and soccer players had an ACL injury 2 to 8 times more frequently than other athletes. This prevalence of a high number of sports-related injuries in the region is expected to boost the demand for tibial components in the country.

Furthermore, the advantages associated with cementless total knee systems (TKS) for the tibial component are also expected to enhance segment growth. For instance, according to an article published by the Journal of Medicine in January 2024, multiple advantages have been associated with the tibial component fixation with cementless total knee systems, including higher preservation of the native bone stock, avoidance of cement debris with subsequent potential third-body wear, and the achievement of a natural bond and osseointegration between the implant and the bone that will provide a durable and stable fixation. Thus, such advantages associated with TKS are expected to boost its usage and, thereby, enhance the segment's growth.

Moreover, the growing geriatric population around the world is also expected to boost segment growth, as TKS is also used for fixation of the tibial component in older people. For instance, according to the United Nations World Population Prospects published in 2022, the share of the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. The source also stated that by 2050, the number of persons aged 65 years or over worldwide is projected to be more than twice the number of children under age five and about the same as the number of children under age 12. Thus, such an increase in the geriatric population is also expected to boost the segment growth.

Therefore, the tibial component segment is expected to witness significant growth over the forecast period due to the abovementioned factors, such as the rising sports injuries, the rising geriatric population, and the growing advantages associated with TKS.

North America is Expected to Hold a Significant Share in the Market During the Forecast Period

North America is expected to hold a significant market share owing to factors such as the easy availability of technologically advanced products and the high awareness of cementless total knee systems in the region. For instance, according to the data updated by the Centers for Disease Control and Prevention (CDC), in February 2024, the age-adjusted prevalence of diagnosed arthritis in adults was 18.9% in 2022 in the United States, which is among the key factors contributing to the growth of the studied market in North America.

Moreover, the rising sports injuries in the region are also expected to boost the market growth. For instance, according to the data published by the National Safety Council of the United States in 2022, it was estimated that 3.6 million people were treated in emergency departments for injuries involving sports and recreational equipment in the United States in 2022. The most common activities frequently associated with injuries were exercise, cycling, and basketball. Thus, the high prevalence of such injuries is expected to boost the usage of cementless total knee systems (TKS) for treatment procedures, thus boosting the market growth.

Furthermore, key product launches, a high concentration of market players, or the manufacturer's presence in the United States are some factors driving the growth of the country's cementless total knee system market. For instance, in March 2022, Johnson & Johnson (DePuy Synthes) added two innovations to the ATTUNE knee portfolio, namely, the Attune Cementless Fixed-bearing Knee with Affixium 3DP Technology and the Attune Medical Stabilized System. These products are used for total knee arthroplasty procedures. Therefore, such product innovations in the region are anticipated to drive market growth in the country.

Therefore, owing to factors such as the rising prevalence of arthritis, the growing number of sports injuries, and developments by key players, the market is expected to flourish in North America.

Cementless Total Knee System (TKS) Industry Overview

The cementless total knee system (TKS) market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold large market shares and are well known, including Stryker, Smith & Nephew, Zimmer Biomet, Johnson & Johnson (DePuy Synthes), B. Braun SE, Olympus Corporation (FH ORTHO), DJO LLC (Enovis), X.NOV (C2F IMPLANTS), and Beijing Chunlizhengda Medical Instruments Co. Ltd.

Cementless Total Knee System (TKS) Market Leaders

Cementless Total Knee System (TKS) Market News

• February 2024: Zimmer Biomet Holdings Inc. showcased the latest innovations across its product portfolio at the 2024 annual meeting of the American Academy of Orthopaedic Surgeons (AAOS). The showcase comprised innovations in its products, including Persona OsseoTi Keel Tibia for cementless knee replacement procedures.
• May 2023: Smith & Nephew Inc. received 510(k) premarket approval for its Legion Total Knee System, including the Legion Conceloc Cementless Total Knee System in the United States.